Cholangiocarcinoma primary prevention: Difference between revisions
Jump to navigation
Jump to search
Farima Kahe (talk | contribs) No edit summary |
Farima Kahe (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cholangiocarcinoma}} | {{Cholangiocarcinoma}} | ||
{{CMG}};{{AE}} {{ | {{CMG}};{{AE}} {{F.K}} | ||
==Overview== | ==Overview== | ||
Effective measures for the primary prevention of cholangiocarcinoma hepatitis B [[vaccination]], weight reduction, avoiding excess alcohol use. | Effective measures for the primary prevention of cholangiocarcinoma hepatitis B [[vaccination]], weight reduction, avoiding excess alcohol use. | ||
Revision as of 20:00, 6 February 2018
|
Cholangiocarcinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cholangiocarcinoma primary prevention On the Web |
|
American Roentgen Ray Society Images of Cholangiocarcinoma primary prevention |
|
Risk calculators and risk factors for Cholangiocarcinoma primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]
Overview
Effective measures for the primary prevention of cholangiocarcinoma hepatitis B vaccination, weight reduction, avoiding excess alcohol use.
Prevention
- Effective measures for the primary prevention of cholangiocarcinoma include:[1][2]
- Hepatitis B vaccination
- Avoiding excess alcohol use
- Weight reduction
- Reducing the consumption of uncooked fish
References
- ↑ Patel T (2011). "Cholangiocarcinoma--controversies and challenges". Nat Rev Gastroenterol Hepatol. 8 (4): 189–200. doi:10.1038/nrgastro.2011.20. PMC 3888819. PMID 21460876.
- ↑ Braconi C, Patel T (2010). "Cholangiocarcinoma: new insights into disease pathogenesis and biology". Infect. Dis. Clin. North Am. 24 (4): 871–84, vii. doi:10.1016/j.idc.2010.07.006. PMC 2954129. PMID 20937455.